PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Microbiology & Immunology, Renaissance School of Medicine of Stony Brook University, Stony Brook, NY, United States.\', \'Department of Medicine, Renaissance School of Medicine of Stony Brook University, Stony Brook, NY, United States.\', \'Department of Biomedical Engineering, Stony Brook University, Stony Brook, NY, United States.\', \'Department of Biochemistry and Molecular Biophysics, Kansas State University, Manhattan, KS, United States.\', \'Pulmonary and Critical Care Division, The Medical University of South Carolina, Charleston, SC, United States.\', \'The Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3389/fimmu.2021.767347
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 34804054
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • SARS-CoV-2 Exacerbates COVID-19 Pathology Through Activation of the Complement and Kinin Systems.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all